Fetzima (Allergan USA, Inc.)


Welcome to the PulseAid listing for the Fetzima drug offered from Allergan USA, Inc.. This Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Allergan USA, Inc.
NON-PROPRIETARY NAME: LEVOMILNACIPRAN HYDROCHLORIDE
SUBSTANCE NAME: LEVOMILNACIPRAN HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-07-25
END MARKETING DATE: 0000-00-00


Fetzima HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFetzima from Allergan USA, Inc.
LABELER NAME: Allergan USA, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 120(mg/1)
START MARKETING DATE: 2013-07-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0456-2212_089df56c-7e5a-48b4-8579-10b9e65ce998
PRODUCT NDC: 0456-2212
APPLICATION NUMBER: NDA204168

Other LEVOMILNACIPRAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan USA, Inc.Fetzima
Avera McKennan HospitalFetzima